APA (7th ed.) Citation

Zielinski, R. J., Grela, K., Cardenas-Zuniga, R., Skora, S., Fokt, I., Gagea, M., . . . Priebe, W. (2024). Abstract LB180: Non-cardiotoxic properties of annamycin, a clinically evaluated anthracycline and potent topoisomerase 2β poison. Cancer research (Chicago, Ill.), 84(7_Supplement), LB180. https://doi.org/10.1158/1538-7445.AM2024-LB180

Chicago Style (17th ed.) Citation

Zielinski, Rafal J., Krzysztof Grela, Roberto Cardenas-Zuniga, Stanislaw Skora, Izabela Fokt, Mihai Gagea, Wolfram Dempke, and Waldemar Priebe. "Abstract LB180: Non-cardiotoxic Properties of Annamycin, a Clinically Evaluated Anthracycline and Potent Topoisomerase 2β Poison." Cancer Research (Chicago, Ill.) 84, no. 7_Supplement (2024): LB180. https://doi.org/10.1158/1538-7445.AM2024-LB180.

MLA (9th ed.) Citation

Zielinski, Rafal J., et al. "Abstract LB180: Non-cardiotoxic Properties of Annamycin, a Clinically Evaluated Anthracycline and Potent Topoisomerase 2β Poison." Cancer Research (Chicago, Ill.), vol. 84, no. 7_Supplement, 2024, p. LB180, https://doi.org/10.1158/1538-7445.AM2024-LB180.